z-logo
open-access-imgOpen Access
NCCN Lung Cancer Guidelines Add New Targeted Agents
Author(s) -
Ed Susman
Publication year - 2005
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000289769.12201.d0
Subject(s) - medicine , erlotinib , lung cancer , stage (stratigraphy) , cancer , disease , radiation therapy , gefitinib , targeted therapy , oncology , intensive care medicine , family medicine , epidermal growth factor receptor , paleontology , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom